Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
CTNNB1 mutations were observed in 117 of 138 (85%) of desmoids.
|
18832571 |
2008 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
To investigate whether this hypothesis could be extended to other Wnt-dependent tumor types, we searched for WT1 mutations and studied WT1 expression in beta-catenin mutant desmoid tumors.
|
15540161 |
2005 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis (desmoid tumor).
|
9736021 |
1998 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Desmoid-type fibromatosis is characterized by CTNNB1 exon 3 mutations, which result in aberrant nuclear β-catenin localization and dysregulated canonical Wnt signaling.
|
27259010 |
2016 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The majority of desmoid tumors are related to T41A and S45F mutations of the beta-catenin encoding gene (CTNNB1).
|
29330550 |
2018 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
Taken together, we propose that TGF-beta is a modulator of beta-Catenin levels in tumoral fibroblasts and non-tumoral fibroblasts, despite the oncogenic mutations already present in this gene in tumoral fibroblasts of desmoid tumors.
|
17601559 |
2007 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
FAP results from germline adenomatous polyposis coli (APC) gene mutations and desmoids arise following biallelic APC mutation, with one change usually occurring distal to the second beta-catenin binding/degradation repeat of the gene (3' to codon 1399).
|
15542524 |
2004 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
Diffuse moderate or strong nuclear staining for beta-catenin was found in all desmoid tumors, 4 of 5 benign SFTs, and 2 of 6 malignant SFTs.
|
17090192 |
2006 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Tumor specimens from 14 patients surgically treated for aggressive fibromatosis (6 familial adenomatous polyposis and 8 sporadic cases), analyzed for adenomatous polyposis coli (APC) and CTNNB1 (beta-catenin) mutations, were further investigated for beta-catenin, cyclooxygenase-2 (COX-2), platelet-derived growth factor (PDGF) receptor alpha (PDGFRA)/PDGF receptor beta (PDGFRB), their cognate ligands (PDGFA and PDGFB), and KIT using a comprehensive immunohistochemical, biochemical, molecular, and cytogenetic approach.
|
17785554 |
2007 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
CTNNB1 mutations were observed in 117 of 138 (85%) of desmoids.
|
18832571 |
2008 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Thus, our case is the 19th pancreatic DTF and the second case with confirmed beta-catenin gene mutation.
|
26907785 |
2016 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
A novel case of a sporadic desmoid tumour with mutation of the beta catenin gene.
|
10655994 |
1999 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Three patients showed a CTNNB1 hotspot mutation (T41A, S45F, or S45N) in both the desmoid-type fibromatosis and the radiation-induced sarcoma.
|
26414222 |
2015 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Additionally, we expanded the spectrum of mutations in CTNNB1 with one novel desmoid mutation.
|
24206198 |
2014 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
We performed IHC of β-catenin and mutation analysis of CTNNB1 and APC in 18 paediatric desmoid tumours, diagnosed between 1990 and 2009 in the Erasmus MC, Rotterdam.
|
22305464 |
2012 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Low-dose chemotherapy with methotrexate and vinblastine for patients with desmoid tumors: relationship to CTNNB1 mutation status.
|
25899770 |
2015 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Taken together, we propose that TGF-beta is a modulator of beta-Catenin levels in tumoral fibroblasts and non-tumoral fibroblasts, despite the oncogenic mutations already present in this gene in tumoral fibroblasts of desmoid tumors.
|
17601559 |
2007 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
We report a case of intrathoracic desmoid tumor without familial adenomatous polyposis and demonstrate beta-catenin mutation of exon 3.
|
16131791 |
2006 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
CTNNB1 mutations were observed in 223 of 254 (88%) of sporadic desmoid tumors.
|
22766794 |
2012 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
There are somatic mutations of the APC and beta-catenin gene in desmoid-type fibromatosis, and there are abnormalities in the Wnt signalling pathway.
|
17558858 |
2007 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Isolated and cultured desmoid tumor cells harboring any one of the CTNNB1 mutation status had unique characteristics, and could be useful to investigate desmoid tumors with different mutation status of CTNNB1.
|
26686699 |
2016 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
CTNNB1 mutations associated to miRNA dysregulation could affect the genesis and the progression of this disease and help histological diagnosis of sporadic DTs.
|
28418912 |
2017 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study.
|
23913621 |
2013 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
No differences in the expression levels of Wnt target genes were observed between the different CTNNB1 mutation types in DTF tumors.
|
30528042 |
2019 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
CTNNB1 mutations are indeed common in sporadic desmoid tumors.
|
23960186 |
2013 |